Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
The 3 Most Undervalued Nasdaq 100 Stocks to Buy: Summer 2024
12:19pm, Tuesday, 11'th Jun 2024
After last year's monstrous 53% gains the Nasdaq 100 is at it again in 2024. Year-to-date (YTD) the popular index is up another 13%.
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10:00pm, Monday, 10'th Jun 2024
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:35pm, Monday, 10'th Jun 2024
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted n
3 No-Brainer Nasdaq Stocks to Buy in June
01:01pm, Monday, 10'th Jun 2024
24/7 Insights The Nasdaq is up a stunning 14.5% this year after a massive 43% gain in 2023.
Nasdaq and S&P 500 to open lower amid political uncertainty; Apple AI event later today
08:38am, Monday, 10'th Jun 2024
US stocks set to open down Apple to unveil AI strategy at conference today Interest rate decision this week 8.35am: Wall Street to open lower In the US, stocks are set to open lower as the markets r
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07:30am, Monday, 10'th Jun 2024
PALO ALTO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic disea
Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
07:00am, Monday, 10'th Jun 2024
BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics
$1,000 in This Vanguard ETF Incurs a Mere $1 Annual Fee, and It Has Beaten the S&P 500 and Nasdaq Composite in 2024
09:15am, Sunday, 09'th Jun 2024
The Vanguard S&P 500 Growth ETF has some distinguishing characteristics. Nearly three-quarters of the fund is concentrated in just three sectors.
2 Top Artificial Intelligence (AI) Stocks to Buy Before the Nasdaq Soars Higher
08:45am, Saturday, 08'th Jun 2024
Nvidia's latest guidance makes it clear that the semiconductor bellwether is set to deliver more upside. Qualcomm's growth is accelerating due to the adoption of AI-enabled smartphones and personal co
Waystar IPO: Stock price will be closely watched today as the healthcare software company debuts on Nasdaq
06:21am, Saturday, 08'th Jun 2024
The name may conjure up memories of HBO's Succession (in which the fictional company at the center of the action is called “Waystar Royco”), but this Waystar is very much real—and it's hitting t
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05:37pm, Friday, 07'th Jun 2024
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on June 6, 2024, the Compensation Committee of Puma's Board of Directors approved the
NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Filing of Annual Report on Form 10-Q
05:00pm, Friday, 07'th Jun 2024
New York, NY, June 07, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from The Nasdaq Stock
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 07'th Jun 2024
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 07'th Jun 2024
SAN FRANCISCO, CA / ACCESSWIRE / June 7, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective June 4, 2024, the Company granted 1,111 restricted stock u
Papaya Growth Opportunity Corp. I Receives Expected Notice from Nasdaq Regarding Delayed Quarterly Filing
04:06pm, Friday, 07'th Jun 2024
Oakland, CA, June 07, 2024 (GLOBE NEWSWIRE) -- Papaya Growth Opportunity Corp. I (NASDAQ: PPYA) (the "Company") announced today that it received a notice ("Notice") from the Listing Qualifications Dep
